Related Experiment Videos
[Anti-phospholipid antibodies and recurrent miscarriage]
P Capel1, A Lambrechts, W Wijns
1Département d'Immunologie, Hématologie et Transfusion, Hôpital Erasme, Bruxelles.
Revue Medicale De Bruxelles
|April 1, 1992
Summary
Antiphospholipid antibodies increase risks of blood clots, low platelets, and fetal loss. Treatment with immunosuppressants or anticoagulants can manage these obstetrical issues, despite diagnostic challenges.
Area of Science:
- Immunology
- Obstetrics
- Hematology
Context:
- Antiphospholipid antibodies are linked to serious health issues including thromboembolism and fetal loss.
- Standardization and specificity issues in laboratory tests complicate antibody detection.
Purpose:
- To summarize the association of antiphospholipid antibodies with thromboembolism and fetal loss.
- To highlight the efficacy of immunosuppressive or anticoagulant treatments for obstetrical complications.
- To address the diagnostic challenges in detecting these antibodies.
Summary:
- Antiphospholipid antibodies are associated with arterial and venous thromboembolism, thrombocytopenia, and fetal loss.
- Obstetrical complications linked to these antibodies can be effectively managed with immunosuppressive or anticoagulant therapies.
- Difficulties in laboratory test standardization and specificity hinder accurate detection of antiphospholipid antibodies.
Impact:
- Improved understanding of antiphospholipid antibody-related risks.
- Guidance on therapeutic strategies for managing associated obstetrical conditions.
- Highlights the need for improved diagnostic methods for antiphospholipid antibodies.